In the last 12 months, insiders at Neurogene Inc. ($NGNE) filed 59 transactions with the SEC: 6 open-market purchases totaling $2,720,023 and 12 sales totaling $672,837. Net insider sentiment: net buying.
Neurogene Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Samsara BioCapital GP, LLC (Not found) — 4 transactions totaling $1,259,623
- McMinn Rachel (Chief Executive Officer) — 7 transactions totaling $1,042,995
- Cvijic Christine Mikail (President and CFO) — 13 transactions totaling $827,665
- Cobb Stuart (Chief Scientific Officer) — 9 transactions totaling $244,449
- Jordan Julie (Chief Medical Officer) — 6 transactions totaling $18,128
View all SEC Filings for Neurogene Inc. (NGNE).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | Jordan Julie | Chief Medical Officer | S | Common Stock | 828 | $21.89 | 12,472.0000 | 21,168,431 | 6.23% | 0.00% |
| March 26, 2026 | Cvijic Christine Mikail | President and CFO | S | Common Stock | 2558 | $21.62 | 103,240.0000 | 21,168,431 | 2.42% | 0.01% |
| March 26, 2026 | McMinn Rachel | Chief Executive Officer | S | Common Stock | 3352 | $22.07 | 1,344,307.0000 | 21,168,431 | 0.25% | 0.02% |
| March 13, 2026 | Cobb Stuart | Chief Scientific Officer | S | Common Stock | 2658 | $21.34 | 30,645.0000 | 21,168,431 | 7.98% | 0.01% |
| March 13, 2026 | Cvijic Christine Mikail | President and CFO | S | Common Stock | 2387 | $20.42 | 107,456.0000 | 21,168,431 | 2.17% | 0.01% |
| March 13, 2026 | Cobb Stuart | Chief Scientific Officer | S | Common Stock | 148 | $22.08 | 30,497.0000 | 21,168,431 | 0.48% | 0.00% |
| March 13, 2026 | Cvijic Christine Mikail | President and CFO | S | Common Stock | 1395 | $21.25 | 106,061.0000 | 21,168,431 | 1.30% | 0.01% |
| March 13, 2026 | Cobb Stuart | Chief Scientific Officer | S | Common Stock | 3991 | $20.41 | 33,303.0000 | 21,168,431 | 10.70% | 0.02% |
| March 13, 2026 | Cvijic Christine Mikail | President and CFO | S | Common Stock | 263 | $22.02 | 105,798.0000 | 21,168,431 | 0.25% | 0.00% |
| Feb. 27, 2026 | Cvijic Christine Mikail | President and CFO | S | Common Stock | 4800 | $25.11 | 109,843.0000 | 21,168,431 | 4.19% | 0.02% |
| Feb. 20, 2026 | Jordan Julie | Chief Medical Officer | A | Stock Option (Right to Buy) | 29600 | $0.00 | 29,600.0000 | 21,168,431 | 9999.99% | 0.14% |
| Feb. 20, 2026 | Cobb Stuart | Chief Scientific Officer | A | Common Stock | 16500 | $0.00 | 37,294.0000 | 21,168,431 | 79.35% | 0.08% |
| Feb. 20, 2026 | PALEKAR ROHAN | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 21,168,431 | 9999.99% | 0.06% |
| Feb. 20, 2026 | McMinn Rachel | Chief Executive Officer | A | Stock Option (Right to Buy) | 155100 | $0.00 | 155,100.0000 | 21,168,431 | 9999.99% | 0.73% |
| Feb. 20, 2026 | McMinn Rachel | Chief Executive Officer | A | Common Stock | 25900 | $0.00 | 1,347,659.0000 | 21,168,431 | 1.96% | 0.12% |
| Feb. 20, 2026 | Cvijic Christine Mikail | President and CFO | A | Stock Option (Right to Buy) | 131900 | $0.00 | 131,900.0000 | 21,168,431 | 9999.99% | 0.62% |
| Feb. 20, 2026 | Cvijic Christine Mikail | President and CFO | A | Common Stock | 22000 | $0.00 | 114,643.0000 | 21,168,431 | 23.75% | 0.10% |
| Feb. 20, 2026 | Jordan Julie | Chief Medical Officer | A | Common Stock | 4900 | $0.00 | 13,300.0000 | 21,168,431 | 58.33% | 0.02% |
| Feb. 20, 2026 | Woods Keith | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 21,168,431 | 9999.99% | 0.06% |
| Feb. 20, 2026 | Freedland Cory S. | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 21,168,431 | 9999.99% | 0.06% |
| Feb. 20, 2026 | Noonberg Sarah B. | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 21,168,431 | 9999.99% | 0.06% |
| Feb. 20, 2026 | BAFFI ROBERT | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 21,168,431 | 9999.99% | 0.06% |
| June 12, 2025 | Woods Robert Keith | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 17,567,082 | 9999.99% | 0.07% |
| June 12, 2025 | BAFFI ROBERT | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 17,567,082 | 9999.99% | 0.07% |
| June 12, 2025 | Noonberg Sarah B. | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 17,567,082 | 9999.99% | 0.07% |
| June 12, 2025 | Freedland Cory S. | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 17,567,082 | 9999.99% | 0.07% |
| June 12, 2025 | PALEKAR ROHAN | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 17,567,082 | 9999.99% | 0.07% |
| May 14, 2025 | Cobb Stuart | Chief Scientific Officer | S | Common Stock | 6797 | $15.15 | 20,794.0000 | 17,567,082 | 24.63% | 0.04% |
| March 26, 2025 | Cobb Stuart | Chief Scientific Officer | A | Employee Stock Option (Right to buy) | 42900 | $0.00 | 42,900.0000 | 17,567,082 | 9999.99% | 0.24% |
| March 26, 2025 | Cobb Stuart | Chief Scientific Officer | A | Common Stock | 7200 | $0.00 | 27,591.0000 | 17,567,082 | 35.31% | 0.04% |
| March 26, 2025 | Cvijic Christine Mikail | President and CFO | A | Common Stock | 20300 | $0.00 | 92,643.0000 | 17,567,082 | 28.06% | 0.12% |
| March 26, 2025 | Cvijic Christine Mikail | President and CFO | A | Employee Stock Option (Right to buy) | 122000 | $0.00 | 122,000.0000 | 17,567,082 | 9999.99% | 0.69% |
| March 26, 2025 | Jordan Julie | Chief Medical Officer | A | Common Stock | 8400 | $0.00 | 8,400.0000 | 17,567,082 | 9999.99% | 0.05% |
| March 26, 2025 | Jordan Julie | Chief Medical Officer | A | Employee Stock Option (Right to buy) | 50300 | $0.00 | 50,300.0000 | 17,567,082 | 9999.99% | 0.29% |
| March 26, 2025 | McMinn Rachel | Chief Executive Officer | A | Common Stock | 23900 | $0.00 | 1,274,259.0000 | 17,567,082 | 1.91% | 0.14% |
| March 26, 2025 | McMinn Rachel | Chief Executive Officer | A | Employee Stock Option (Right to buy) | 143500 | $0.00 | 143,500.0000 | 17,567,082 | 9999.99% | 0.82% |
| March 13, 2025 | Cvijic Christine Mikail | President and CFO | S | Common Stock | 4501 | $16.94 | 72,343.0000 | 17,567,082 | 5.86% | 0.03% |
| Nov. 26, 2024 | Samsara BioCapital GP, LLC | Not found | P | Common Stock | 20748 | $24.91 | 1,689,105.0000 | 16,953,443 | 1.24% | 0.12% |
| Nov. 26, 2024 | Samsara BioCapital GP, LLC | Not found | P | Common Stock | 10803 | $26.01 | 1,699,908.0000 | 16,953,443 | 0.64% | 0.06% |
| Nov. 26, 2024 | Samsara BioCapital GP, LLC | Not found | P | Common Stock | 15219 | $26.73 | 1,715,127.0000 | 16,953,443 | 0.90% | 0.09% |
| Nov. 26, 2024 | Samsara BioCapital GP, LLC | Not found | P | Common Stock | 2000 | $27.50 | 1,717,127.0000 | 16,953,443 | 0.12% | 0.01% |
| Nov. 22, 2024 | McMinn Rachel | Chief Executive Officer | P | Common Stock | 47500 | $20.40 | 1,297,859.0000 | 16,953,443 | 3.80% | 0.28% |
| Nov. 22, 2024 | Cvijic Christine Mikail | President and CFO | P | Common Stock | 24000 | $20.48 | 76,844.0000 | 16,953,443 | 45.42% | 0.14% |
| June 14, 2024 | Freedland Cory S. | Director | A | Stock Option (Right to Buy) | 7700 | $0.00 | 7,700.0000 | 4,656,947 | 9999.99% | 0.17% |
| June 14, 2024 | Noonberg Sarah B. | Director | A | Stock Option (Right to Buy) | 7700 | $0.00 | 7,700.0000 | 4,656,947 | 9999.99% | 0.17% |
| June 14, 2024 | BAFFI ROBERT | Director | A | Stock Option (Right to Buy) | 7700 | $0.00 | 7,700.0000 | 4,656,947 | 9999.99% | 0.17% |
| June 14, 2024 | PALEKAR ROHAN | Director | A | Stock Option (Right to Buy) | 7700 | $0.00 | 7,700.0000 | 4,656,947 | 9999.99% | 0.17% |
| June 14, 2024 | Woods Robert Keith | Director | A | Stock Option (Right to Buy) | 7700 | $0.00 | 7,700.0000 | 4,656,947 | 9999.99% | 0.17% |
| March 13, 2024 | Cobb Stuart | Chief Scientific Officer | A | Common Stock | 20391 | $0.00 | 20,391.0000 | 4,656,947 | 9999.99% | 0.44% |
| March 13, 2024 | Cvijic Christine Mikail | President and CFO | A | Employee Stock Option (Right to buy) | 53900 | $0.00 | 53,900.0000 | 4,656,947 | 9999.99% | 1.16% |
| March 13, 2024 | Cvijic Christine Mikail | President and CFO | A | Common Stock | 31903 | $0.00 | 52,844.0000 | 4,656,947 | 152.35% | 0.69% |
| March 13, 2024 | McMinn Rachel | Chief Executive Officer | A | Employee Stock Option (Right to buy) | 93282 | $0.00 | 93,282.0000 | 4,656,947 | 9999.99% | 2.00% |
| March 13, 2024 | Cobb Stuart | Chief Scientific Officer | A | Stock Option (Right to Buy) | 34450 | $0.00 | 34,450.0000 | 4,656,947 | 9999.99% | 0.74% |
| Jan. 16, 2024 | PALEKAR ROHAN | Not found | A | Stock Option (Right to Buy) | 15400 | $0.00 | 15,400.0000 | 4,656,947 | 9999.99% | 0.33% |
| Jan. 16, 2024 | Jordan Julie | Chief Medical Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 4,656,947 | 9999.99% | 1.61% |
| Jan. 16, 2024 | Noonberg Sarah B. | Not found | A | Stock Option (Right to Buy) | 15400 | $0.00 | 15,400.0000 | 4,656,947 | 9999.99% | 0.33% |
| Jan. 16, 2024 | Freedland Cory S. | Not found | A | Stock Option (Right to Buy) | 15400 | $0.00 | 15,400.0000 | 4,656,947 | 9999.99% | 0.33% |
| Jan. 16, 2024 | BAFFI ROBERT | Not found | A | Stock Option (Right to Buy) | 15400 | $0.00 | 15,400.0000 | 4,656,947 | 9999.99% | 0.33% |
| Jan. 16, 2024 | Woods Robert Keith | Not found | A | Stock Option (Right to Buy) | 15400 | $0.00 | 15,400.0000 | 4,656,947 | 9999.99% | 0.33% |